TP53 and cancer: We observed that knocking down MDM2 suppressed HepG2 cell proliferation and migration, in line with these observations that have shown that MDM2 possesses proliferation- and migration-promoting activities in HCC and several other human cancers, independent of p53 [24, 25, 54].